Intrathecal administration of dizocilpine maleate (MK-801) attenuates ischemic damage in the rabbit spinal cord

Experimental Neurology

Volumn 130, Issue 2, 1994, Pages 337-343

  Saganová, Kamila ^a   Maršala, Martin ^a  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0028609838     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1994.1212     Document Type: Article

References (56)

1. Alberts, G. W., M. P. Goldberg, and D. W. Choi. 1992. Do 20. NMDA antagonists prevent neuronal injury? Yes. Arch. Neurol. 49:418-420.
2. BESSON, J. M., R. F. H. CATCHLOVE, P. FELTZ, and D. LE BARS. 1974. Further evidence for postsynaptic inhibition on lamina V. dorsal horn interneurons. Brain Res. 66: 531-536.
3. BUCHAN, A. M. 1992. Do NMDA antagonists prevent neuronal injury? No. Arch. Neurol. 49: 420-421.
4. CAMMERMAYER, J. 1961. The importance of avoiding “dark”, neurons in experimental neuropathology. Acta Neuropathol. 1: 245-270.
5. CAMMERMAYER, J. 1978. Is the solitary dark neuron a manifestation of postmortem trauma to the brain inadequately fixed by perfusion? Histochemistry 56, 97-115.
6. CHASE, R. A., S. PERSON, P. NUNN, and P. L. LANTOS. 1985. Comparative toxicities of a-and ß-iV-oxalyl-1-a, a, ß-diaminopro-prionic acids to the rat spinal cord. Neurosci. Lett. 55: 89-94.
7. CHOI, D. W. 1990. Possible mechanisms limiting iV-methyl-D-aspartate receptor overactivation and the therapeutic efficacy of jV-methyl-D-aspartate antagonist. Stroke 219 (suppl. III): III-20-25, III-22.
8. CRAIN, B. J., W. D. WESTERKAM, A. H. HARRISON, and J. V. NADLER. 1988. Selective neuronal death after transient forebrain, ischemia in the mongolian gerbil: A silver impregnation study. Neuroscience 27: 387-402.
9. DEGIROLAMI, U., and J. A. ZIVIN. 1982. Neuropathology of experimental spinal cord ischemia in the rabbit. J. Neuropathol. Exp. Neurol. 41: 129-149.
10. DIRNAGL, U., J. TANABE, and W. PULSINELLI. 1990. Pre-and post-treatment with MK-801 but not pretreatment alone reduces neocortical damage after focal cerebral ischemia in the rat. Exp. Neurol. 108: 232-240.
11. Faden, A. I., T. P. Jacobs, M. T. Smith, and J. A. Zivin. 1984. Naloxone in experimental spinal cord ischemia: Dose-response studies. Eur. J. Pharmacol. 103: 115-120.
12. Faden, A. I., and E. P. Simon. 1988. A potential role for excitotoxins in the pathophysiology of spinal cord injury. Ann. Neurol. 23: 623-626.
13. Fercáková, A., G. Halát, M. Marsala, N. Lukácová, and J. Marsala. 1992. Graded postischemic reoxygenation reduces lipid peroxidation and reperfusion injury in the rabbit spinal cord. Brain Res. 593: 159-167.
14. FINK, R. P., and L. Heimer. 1967. Two methods for selective silver impregnation of degenerating axons and their synaptic endings in the central nervous system. Brain Res. 4: 369-374.
15. Gallyas, F., F. H. Guldner, G. Zoltay, and J. R. Wolf. 1990. Golgi-like demonstration of “dark” neurons with an argyrophil III. method for experimental neuropathology. Acta Neuropathol. 79:620-628.
16. Gallyas, F., M. Hsu, and G. Buzsaki. 1993. Four modified silver methods for thick sections of formaldehyde-fixed mammalian central nervous tissue: ‘Dark* neurons, perikarya of all neurons, microglial cells and capillaries. J. Neurosci. Methods. 50: 159-164.
17. GARDNER, V. O., V. J. CAIOZZO, S. K. MUNDEN, and R. J. BRIDGES. 1990. Excitotoxins can produce protein degradation in the spinal cord. Spine 15: 858-863.
18. Glees, P. 1946. Terminal degeneration within the central ner-vous system as studied by a new silver method. J. Neuropathol. Exp. Neurol. 5: 54-59.
19. Greenamyre, J. T., A. B. Young, and J. B. Pemrey. 1984. Quantitative autoradiographic distribution of L-[ Hj glutamate-binding sites in rat central nervous system. J. Neurosci. 4: 2133-2144.
20. HEIMER, L. 1970. Selective silver-impregnation of degenerating axoplasm. Pages 106-131 in W. J. H. Nauta and S. O. E. Ebesson, Eds., Contemporary Research Methods in Neuroanatomy. Springer-Verlag, Berlin/Heidelberg/New York.
21. Hao, J. X., X. J. Xu, H. Aldskogius, A. Seiger, and Z. Wiesenfeld-Hallin. 1991. The excitatory amino acid receptor antagonist MK-801 prevents the hypersensitivity induced by spinal cord ischemia in the rat. Exp. Neurol. 113: 182-191.
22. Iizuka, H., K. Sakatani, and W. Young. 1989. Selective cortical neuronal damage after middle cerebral artery occlusion in rats. Stroke 20: 1516-1523.
23. Jacobs, T. P., E. Shohami, W. Baze, E. Burgard, C. Gunderson, J. M. Hallenbeck, and G. Feurstein. 1987. Deteriorating stroke model: Histopathology, edema, and eicosanoid changes following spinal cord ischemia in rabbits. Stroke 18: 741-750.
24. Kochhar, A., J. A. Zivin, P. D. Lyden, and V. Mazzarella. 1988. Glutamate antagonist therapy reduces neurologic deficits pro-duced by focal central nervous system ischemia. Arch. Neurol. 45:148-153.
25. LAMOTTE, C. C. 1986. Organization of dorsal horn neurotransmit-ter systems. Pages 97-116 in T. L. Yaksh, Ed, Spinal Afferent Processing. Plenum, New York.
26. Langerman, L., G. Chaimsky, E. Golomb, M. Tverskoy, A. I. Kook, and S. Benita. 1990. A rabbit model for evaluation of spinal anesthesia: Chronic cannulation of the subarachnoid space. Anesth. Analg. 71: 529-535.
27. Marsala, J., I. Sulla, M. Santa, M. Marsala, E. Mechirova, and P. Jalc. 1989. Early neurohistopathological changes of canine lumbosacral spinal cord segments in ischemia-reperfusion-induced paraplegia. Neurosci. Lett. 106: 83-88.
28. MARSALA, J., I. SULLA, M. SANTA, M. MARSALA, L. ZACHARIAS, and J. RADOÑÁK. 1991. Mapping of the canine lumbosacral spinal cord neurons by Nauta method at the end of the early phase of paraplegia induced by ischemia and reperfusion. Neuroscience 45:479-494.
29. MARSALA, J., M. MARSALA, I. VANICKY, J. GALIK, and J. OREND-ACOVA. 1992. Post cardiac arrest hyperoxic resuscitation enhances neuronal vulnerability of the respiratory rhythm genera-tor and some brainstem and spinal cord neuronal pools in the dog. Neurosci. Lett, 146: 121-124.
30. MARSALA, J., M. MARSALA, I. VANICKY, L. ZACHARIAS, and J. ORENDACOVA. 1993. A new applicability of the suppressive Nauta method in the early phase of neuronal damage. Fund. Dev. Morphol. 3: 269-276.
31. MARTINEZ-ARIZAHA, A., D. D. RIGAMONTI, J. B. LONG, J. KRAIMER, and J. W. HOLADAY. 1990. Effects of NMDA receptor antagonists following spinal ischemia in the rabbit. Exp. Neurol. 108: 252-280.
32. MARTINIAK, J., K. SAGANOVÁ, and M. CHAVKO. 1991. Free and peptide-bound amino acids as indicators of ischemic damage of the rabbit spinal cord. J. Neuropathol. Exp. Neurol. 50: 73-81.
33. NAG, S., and R. J. RIOPELLE. 1990. Spinal neuronal pathology associated with continuous infusion of JV-methyl-D-aspartate in the rat. Acta Neuropathol. 81: 7-13.
34. NAG, S. 1992. Vascular changes in the spinal cord in iV-methyl-D-aspartate-induced excitotoxicity: Morphological and permeability studies. Acta Neuropathol. 84: 471-477.
35. NÄSSTROM, J., U. KARLSSON, and C. POST. 1992. Antinociceptive actions of different classes of excitatory amino acid receptor antagonists in mice. Eur. J. Pharmacol. 212: 21-29.
36. NASSTROM, J., E. BOO, M. STAHLBERG, and O. G. BERGE. 1993. Tissue distribution of two NMDA receptor antagonists, [3H]CGS 19755 and [3H]MK-801, after intrathecal injection in mice. Pharmacol. Biochem. Behav. 44: 9-15.
37. NAUTA, W. J. H. 1950. Uber die sogenannte terminale Degeneration im Zentralnervensystem und ihre Darstellung durch Sil-berimpregnägnation. Arch. Neurol. Psychiatry 66: 353-376.
38. NAUTA, W. J. H., and P. A. GYGAX. 1951. Silver impregnation of degenerating axon terminals in the central nervous system: (1) Technic, (2) Chemical notes. Stain Technol. 26: 5-11.
39. NAUTA, W. J. H., and L. F. RYAN. 1952. Selective impregnation of degenerating axons in the central nervous system. Stain Technol. 27:175-179.
40. NAUTA, W. J. H., and P. A. GYGAX. 1954. Silver impregnation of degenerating axons in the central nervous system: A modified technique. Stain Technol. 29: 91-93.
41. NAUTA, W. J. H. 1957. Silver impregnation of degenerating axons. Pages 17-26 in W. F. Windle, Ed., New Research Techniques of Neuroanatomy. Thomas, Springfield, IL.
42. Ozyurt, E., D. I. Graham, G. N. Woodruf, J. McCulloch. 1988. Protective effect of glutamate antagonist MK-801 in focal cerebral ischemia in the cat. J. Cereb. Blood Flow Metab. 8:138-143.
43. PARK, C. K., D. G. NEHLS, D. I. GRAHAM, G. M. TEASDALE, and J. MCCULOCH. 1988. The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat. Ann. Neurol. 24: 543-551.
44. PARK, C. K., D. G. NEHLS, D.I. GRAHAM, G. M. TEASDALE, and J. McCuloch. 1988. Focal cerebral ischemia in the cat: Treatment with the glutamate antagonist MK-801 after induction of isch-aemia. J. Cereb. Blood Flow Metab. 8: 757-762.
45. Pisharodi, M., and H. J. Nauta. 1985. An animal model for neuron-specific spinal cord lesions by the microinjection of N-methyl-D-aspartate, kainic acid and quisqualic acid. Appl. Neurophysiol. 48: 226-233.
46. Rexed, B. 1952. The cytoarchitectonie organization of the spinal cord in the cat. J. Comp. Neurol. 96: 415-495.
47. REXED, B. 1954. A cytoarchitectonie atlas of the spinal cord in the cat. J. Comp. Neurol. 100: 297-379.
48. Rothman, S. M., and J. W. Olney. 1986. Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann. Neurol. 19:105-111.
49. Saganová, K., and J. Marsala. 1991. Neuropathological analysis of ischemic and reoxygenic injury in rabbit spinal cord. Anat. Anz. (Suppl.) 172: 259.
50. STEWART, G. R., J. W. OLNEY, M. PATHICONDA, and W. D. SNIDER. 1991. Excitotoxicity in the embryonic chick spinal cord. Ann. Neurol. 30: 758-766.
51. Vanicky, I., M. Marsala, J. Orenpácová, and J. Marsala. 1992. Silver impregnability of ischemia-sensitive neocortical neurons after 15 minutes of cardiac arrest in the dog. Anat. Embryol. 186: 167-173.
52. Wong, E. H. F., J. A. Kemp, T. Priestly, A. R. Khight, G. N. Woodruff, L. I. Iversen. 1986. The anticonvulsant MK-801 is a potent iV-methyl-D-aspartate antagonist. Proc. Natl. Acad. Sci. USA 83: 7104.
53. YAKSH, T. L. 1986. The central pharmacology of primary affer-ents with emphasis on the disposition and role of primary afferent substance P. Pages 165-196 in T. L. Yaksh, Ed., Spinal Afferent Processing. Plenum, New York.
54. Yum, S. W., and A. I. Faden. 1990. Comparison of the neuropro-tective effects of the N-methyl-D-aspartate antagonist MK-801 and the opiate-receptor antagonist nalmefene in experimental spinal cord ischemia. Arch. Neurol. 47: 277-281.
55. ZIEGLGANSBERGER, W., and E. A. Puil. 1973. Action of glutamic acid on spinal neurons. Exp. Brain Res. 17: 35-49.
56. Zivin, J. A., and U. DeGirolami. 1980. Spinal cord infarction: A highly reproducible stroke model. Stroke 11: 200-202.